Dow Jumps 210 Points On Vaccine News From AstraZeneca
- 4 years ago
On Monday, US stocks rose.
AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%.
This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness.
S&P 500: 3,580.82, up 0.7%
Dow Jones industrial average: 29,473.41, up 0.7% (210 points)
Nasdaq composite: 11,929.04, up 0.6%
AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%.
This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness.
S&P 500: 3,580.82, up 0.7%
Dow Jones industrial average: 29,473.41, up 0.7% (210 points)
Nasdaq composite: 11,929.04, up 0.6%